In a recent final analysis of a phase 3 trial, the bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine maintained high efficacy and a favorable safety profile against RSV-associated ...

On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for ...

Among 69 hospitalisations of infants for respiratory syncytial virus (RSV)–related lower respiratory tract infection (LRTI) in a Spanish study, 65.2% occurred despite the administration of nirsevimab.

Very severe medically attended RSV-associated LRTI was defined as infection for which hospitalization and supplemental oxygen or intravenous fluids were warranted. Data are from the intention-to-treat ...

Background: Influenzavirus (Flu) is associated with high morbidity in children less than 24-mo old, with high rates of hospitalization. Recommendation for annual influenza vaccination has been ...